Single Source: National Longitudinal Study of Adolescent to Adult (Add) Health Wave VII (U01 Clinical Trial Not Allowed)

The summary for the Single Source: National Longitudinal Study of Adolescent to Adult (Add) Health Wave VII (U01 Clinical Trial Not Allowed) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Single Source: National Longitudinal Study of Adolescent to Adult (Add) Health Wave VII (U01 Clinical Trial Not Allowed): Add Health is a nationally representative, longitudinal cohort study of individuals primarily born from 1976 through 1982 who were first interviewed as adolescents in grades 7-12 (ages 12-19) in 1994-1995. Add Health respondents are now at midlife, offering a uniquely valuable timepoint to assess risk and resilience for Alzheimers disease and related dementias (AD/ADRD). This NOFO will continue core study aspects including the mixed-mode survey, in-home health visit, venous blood collection, and data dissemination activities while further developing Add Health as a population-representative data resource to understand life course factors shaping inequities in outcomes related to aging and AD/ADRD.

Federal Grant Title:	Single Source: National Longitudinal Study of Adolescent to Adult (Add) Health Wave VII (U01 Clinical Trial Not Allowed)
Federal Agency Name:	National Institutes of Health (HHS-NIH11)
Grant Categories:	Education, Health, Income Security and Social Services
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-AG-26-001
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.279, 93.865, 93.866
CFDA Descriptions:	Information not provided
Current Application Deadline:	October 17th, 2025
Original Application Deadline:	October 17th, 2025
Posted Date:	June 16th, 2025
Creation Date:	June 16th, 2025
Archive Date:	November 22nd, 2025
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching:	No
Last Updated:	June 16th, 2025

Applicants Eligible for this Grant: Public and State controlled institutions of higher education
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Link to Full Grant Announcement: https://grants.nih.gov/grants/guide/rfa-files/RFA-AG-26-001.html
Grant Announcement Contact: NIH Grants Information
[email protected]
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Similar Government Grants: • Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and P...; • Grand Opportunity in Medications Development for Substance-Use Disorders (U01 Clinical Tri...; • Development of Medications to Prevent and Treat Substance Use Disorders and Overdose (UG3/...; • Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not ...; • Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Cli...; • NIDA Phase II Small Business Innovation Research (SBIR [R44]) Competing Renewal Awards; • Drug Abuse Aspects of Hiv/Aids and Other Infections; • Epidemiology of Drug Abuse
More Grants from the National Institutes of Health: • Single Source: National Centralized Repository for Alzheimer's Disease and Related Dementi...; • Tobacco Regulatory Science Small Grant Program for New Investigators (R03 Clinical Trial O...; • Environmental influences on Child Health Outcomes (ECHO) Cohort Data and Biospecimen Acces...; • Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed...; • Limited Competition: Regenerative Medicine Innovation Project (RMIP) Investigator-Initiate...